Literature DB >> 1709061

Solitary minute hepatocellular carcinoma. A study of 14 patients.

X D Zhou1, Z Y Tang, Y Q Yu, Z C Ma, B H Yang, J Z Lu, Z Y Lin, J Wang.   

Abstract

Fourteen patients with clinical Stage I hepatocellular carcinoma (T1N0M0) were studied. All patients were asymptomatic, and their conditions were detected by alpha-fetoprotein (AFP) serosurvey and/or ultrasonography (US) either in the natural population in the early years of the study or in the high-risk population in the later years of the study. Cirrhosis was present in all patients. Radical resection was performed in all patients. There were no operative deaths or hospital deaths in this series. The 5-year survival rate after resection was 100%. There were seven long-term survivors in this series (14.2 years (alive), 11.3 years (alive), 8.8 years (alive), 8.8 years, 7.9 years, 7.6 years (alive), and 7.2 years after resection). The authors discuss aspects concerning early diagnosis, treatment, and prognosis of hepatocellular carcinoma (HCC).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709061     DOI: 10.1002/1097-0142(19910601)67:11<2855::aid-cncr2820671125>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Hepatocellular carcinoma.

Authors:  T Ezaki
Journal:  BMJ       Date:  1992-01-25

2.  Recurrence after resection of alpha-fetoprotein-positive hepatocellular carcinoma.

Authors:  X D Zhou; Z Y Tang; Y Q Yu; B H Yang; J Z Lu; Z Y Lin; Z C Ma; B H Zhang
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

3.  Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases.

Authors:  Xin-Da Zhou; Zhao-You Tang; Zeng-Chen Ma; Jia Fan; Zhi-Quan Wu; Lun-Xiu Qin; Jian Zhou; Yao Yu; Hui-Chuan Sun; Shuang-Jian Qiu
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-18       Impact factor: 4.553

4.  Long-term results of surgery for small primary liver cancer in 514 adults.

Authors:  X D Zhou; Z Y Tang; Y Q Yu; B H Yang; Z Y Lin; J Z Lu; Z C Ma
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.